Loading resource…

Springer International Publishing AG
This fourth‑edition volume provides detailed information on pharmacokinetic and pharmacodynamic interactions between antimicrobial agents and commonly used concomitant drugs. It includes case‑based discussions such as daptomycin combined with HMG‑CoA reductase inhibitors and the resulting risk of rhabdomyolysis, as well as antiviral‑immunosuppressant interactions involving acyclovir and mycophenolate mofetil. The text emphasizes practical monitoring recommendations for clinicians managing complex therapy regimens in patients with infections. It is authored by experts in pharmacy and infectious disease and is part of the Springer Infectious Disease series.
No account needed